May 14, 2008
ADVOCATES FOR PLASMA PROTEIN THERAPIES MEET WITH LEGISLATORS TODAY
WASHINGTON, DC--May 14, 2008-Today, another milestone is achieved in the plasma protein users community. National consumer organizations representing individuals with bleeding disorders such as hemophilia, alpha-1 antitrypsin deficiency, primary immune deficiency and advocates for plasma protein therapies joined industry to advocate together in furtherance of patient access to life sustaining plasma protein therapies.
April 23, 2008
PATIENTS WITH RARE, LIFE THREATENING DISEASES MEET WITH MINNESOTA STATE LEGISLATORS TODAY
ST. PAUL, MN-April 23, 2008-Today, individuals with primary immune deficiency diseases, hemophilia and alpha-1 antitrypsin deficiency will meet with state legislators to educate them on the need for a health care system that ensures them access to the life-saving therapies they need.
March 19, 2008
Patients with Rare, Life-threatening Diseases Meet with Florida State Legislators Today
TALLAHASSEE, FL--March 19, 2008--Today, individuals with hemophilia and primary immune deficiency will meet with state legislators to educate them on the need for a health care system that ensures them access to the life-saving therapies they need.
February 27, 2008
Paolo Marcucci Has Joined PPTA's Global Board of Directors
ANNAPOLIS, MD—February 25, 2008—Paolo Marcucci, President and CEO of Kedrion, a company specializing in the development, production and distribution of plasma-derived products, has joined the Global Board of Directors of the Plasma Protein Therapeutics Association (PPTA).
Find older Press Releases in our archive.